{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:14:10Z","timestamp":1789668850986,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.arth.2025.09.026","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:07:30Z","timestamp":1758582450000},"page":"1525-1532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Aspirin: The Safest Prophylactic Approach for Venous Thromboembolism Prevention Following Total Hip Arthroplasty Across All Risk Profiles"],"prefix":"10.1016","volume":"41","author":[{"given":"Joshua R.","family":"Porto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monish S.","family":"Lavu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Christian J.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-2756","authenticated-orcid":false,"given":"Atul F.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.09.026_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.09.026_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/1553350620947209","article-title":"Hallmarks in the history and development of total hip arthroplasty","volume":"27","author":"Markatos","year":"2020","journal-title":"Surg Innov"},{"key":"10.1016\/j.arth.2025.09.026_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & knee","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.09.026_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.09.026_bib5","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.arth.2024.01.050","article-title":"Trends in deep vein thrombosis prophylaxis after total knee arthroplasty: 2016 to 2021","volume":"39","author":"Dubin","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.09.026_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1381612828666220418090928","article-title":"Prophylaxis for venous thromboembolic events in elective total hip and total knee arthroplasty","volume":"28","author":"Karasavvidis","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arth.2025.09.026_bib7","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2106\/JBJS.20.02250","article-title":"Venous thromboembolic prophylaxis after total hip and knee arthroplasty","volume":"103","author":"Lieberman","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.09.026_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250096","article-title":"Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: a PRISMA-compliant Bayesian network meta-analysis","volume":"16","author":"He","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.arth.2025.09.026_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1615\/JLongTermEffMedImplants.v17.i4.90","article-title":"Aggressive anticoagulation after TJA: an evaluation of the ACCP guidelines for thromboprophylaxis","volume":"17","author":"Parvizi","year":"2007","journal-title":"J Long Term Eff Med Implants"},{"key":"10.1016\/j.arth.2025.09.026_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arth.2021.10.001","article-title":"Aspirin thromboprophylaxis is associated with less major bleeding events following total joint arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.09.026_bib11","first-page":"1","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arth.2025.09.026_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arth.2025.09.026_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.09.026_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.arth.2016.09.006","article-title":"Pulmonary embolism rates following total hip arthroplasty with prophylactic anticoagulation: some pulmonary emboli cannot Be avoided","volume":"32","author":"Lieberman","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.09.026_bib15","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.artd.2022.08.008","article-title":"Incidence, risk factors, and subsequent complications of postoperative hematomas requiring reoperation after primary total hip arthroplasty","volume":"19","author":"Pathak","year":"2022","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.09.026_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2106\/JBJS.9408edit","article-title":"Preventing venous thromboembolic disease in patients undergoing elective total hip and knee arthroplasty","volume":"94","author":"Mont","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.09.026_bib17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.23.01158","article-title":"Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles","volume":"106","author":"Lavu","year":"2024","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.arth.2025.09.026_bib18","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.09.026_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.09.026_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5435\/00124635-200903000-00007","article-title":"Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"17","author":"Johanson","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.09.026_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jor.2021.02.005","article-title":"Low dose aspirin is effective in preventing venous thromboembolism in patients undergoing primary total knee arthroplasty","volume":"24","author":"Merkow","year":"2021","journal-title":"J Orthop"},{"key":"10.1016\/j.arth.2025.09.026_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arth.2025.09.026_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jeo2.70010","article-title":"Comparative efficacy of aspirin versus direct oral anticoagulants for venous thromboembolism prophylaxis following primary total hip arthroplasty or total knee arthroplasty: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Syed","year":"2024","journal-title":"J Exp Orthop"},{"key":"10.1016\/j.arth.2025.09.026_bib24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2106\/JBJS.20.01105","article-title":"Recent trends in medicare utilization and reimbursement for orthopaedic procedures performed at ambulatory surgery centers","volume":"103","author":"Lopez","year":"2021","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.arth.2025.09.026_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2106\/00004623-200701000-00005","article-title":"Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty","volume":"89","author":"Patel","year":"2007","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.arth.2025.09.026_bib26","article-title":"Effect of aspirin vs enoxaparin on 90-day mortality in patients undergoing hip or knee arthroplasty: a secondary analysis of the cristal cluster randomized trial","volume":"6","author":"Sidhu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2025.09.026_bib27","article-title":"Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.arth.2025.09.026_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.arth.2025.09.026_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.artd.2018.02.014","article-title":"What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?","volume":"4","author":"Shahi","year":"2018","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.09.026_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2106\/JBJS.23.00824","article-title":"Effect of aspirin versus low-molecular-weight heparin thromboprophylaxis on medication satisfaction and out-of-pocket costs: a secondary analysis of a randomized clinical trial","volume":"106","author":"O'Hara","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.09.026_bib31","article-title":"Aspirin compared with other anticoagulants for use as venous thromboembolism prophylaxis in elective orthopaedic hip and knee operations: a narrative literature review","volume":"13","author":"Olukoya","year":"2021","journal-title":"Cureus"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088354032501215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088354032501215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:45:11Z","timestamp":1775907911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088354032501215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S088354032501215X"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.09.026","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Aspirin: The Safest Prophylactic Approach for Venous Thromboembolism Prevention Following Total Hip Arthroplasty Across All Risk Profiles","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}